Home » Kleresca Approved in EU for Dermatological Platform
Kleresca Approved in EU for Dermatological Platform
Dermatological device developer Kleresca gained a CE Mark for its biophotonic dermatological system.
The device uses a non-invasive fluorescent light treatment to encourage the skin’s biological processes, repair skin in patients and treat rosacea. It can also be used as an add-on treatment for other dermatological procedures, such as laser treatments.
The device cannot cause a photosensitive reaction because the treatment gel is not absorbed by the skin, and the treatment does not damage the skin’s natural barriers.
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct